Affiliate Disclosure: This content contains affiliate links to health providers and services. BestMedsHub may receive compensation when you click through and take action. This compensation may impact how and where products and providers appear on this site. BestMedsHub does not include all providers or products available in the marketplace. This information is not medical advice — always consult a qualified healthcare professional.
Verdict: Hers is a legitimate, convenient way to get brand-name GLP-1 weight-loss medication (Wegovy, Ozempic, Zepbound) online, backed by a profitable public company. It earns a mid-to-lower score in our weight-loss rankings because it is cash-pay only, layers a membership fee on top of the drug cost, and carries more 2025–26 regulatory baggage than its peers — baggage it has since addressed by pivoting away from compounded copies to FDA-approved medications.
What Hers Weight Loss actually offers now
This is the most important thing to understand about Hers in 2026: the program is now brand-name-first. After the FDA declared the semaglutide shortage over in early 2025 and the compounding window closed, Hims & Hers had a turbulent year — but in March 2026 it signed a renewed deal with Novo Nordisk and now prescribes FDA-approved medications rather than compounded “copies.”
| Medication | Type | Starting price* |
|---|---|---|
| Wegovy (semaglutide) | Injectable GLP-1 | from $199/mo |
| Ozempic (semaglutide) | Injectable GLP-1 | from $199/mo |
| Zepbound / Mounjaro (tirzepatide) | Injectable GLP-1/GIP | from $299/mo |
| Oral GLP-1 options | Oral | from $149/mo |
*Medication price only — a separate membership applies (see below). Starting prices reflect Hers’ published “from” pricing and can vary by dose and eligibility. Wegovy and Ozempic are supplied through Hers’ renewed Novo Nordisk partnership; tirzepatide (Zepbound, Mounjaro) is Eli Lilly’s. The process is fully online: you complete an eligibility questionnaire, a licensed clinician reviews it, and approved prescriptions are filled by a partner pharmacy and shipped to your door. For a broader view of the field, see our weight-loss provider comparison and our roundup of the best GLP-1 providers for weight loss.
How much Hers weight loss really costs
Hers advertises medication “from $149/month,” but that is not the full picture. A membership fee is billed separately and on top of the medication:
| Line item | Cost |
|---|---|
| Membership | $39 first month, then $149/mo |
| Medication (oral) | from $149/mo |
| Medication (injectable) | $199–$299/mo |
| Realistic all-in (oral tier) | ~$298–$348/mo |
The ~$298–$348/month figure is for the lowest-cost oral tier; choosing an injectable such as Zepbound pushes the all-in cost higher. Hers is cash-pay and does not bill insurance. If insurance coverage matters to you, read our guide to weight-loss medication insurance coverage before committing. To understand the underlying medications, our Ozempic vs. Wegovy and best weight-loss medications guides are good starting points.
Who qualifies
Hers follows standard GLP-1 eligibility: generally a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. A licensed clinician makes the final determination after your online evaluation, and some applicants will not be approved. See how to get prescribed weight-loss medication for what to expect.
Is Hers legit? An honest look
The case for trust: Hers is operated by Hims & Hers Health, Inc. (NYSE: HIMS) — a GAAP-profitable public company that reported roughly $2.35B in 2025 revenue and more than 2.5 million subscribers. It owns licensed US pharmacies, uses licensed clinicians, displays a LegitScript Certified seal, and holds a BBB A+ rating (accredited since 2018).
What you should also know: Hers had a genuinely rocky 2025–26. It received an FDA warning letter (September 2025) over how it marketed compounded GLP-1s, drew FTC and SEC inquiries, faced securities class-action suits, and Novo Nordisk publicly terminated an earlier partnership in mid-2025, accusing the company of selling “knockoff” compounded versions of Wegovy. Hers disputed the characterization, then reconciled with Novo Nordisk in March 2026, stopped advertising compounded GLP-1, and moved to brand-name medications. The most common customer complaint, per the BBB, is difficulty canceling subscriptions and getting refunds — so set a calendar reminder before any renewal and read the cancellation terms.
Hers vs. Ro, Hims, and Noom
Hers’ real edge is breadth and brand-name access at a transparent cash price under a large, profitable parent. Versus Ro — also a Novo/Lilly partner with a similar brand-name model — Hers carries more recent regulatory history. Versus Hims, it is the same company and platform with women-focused branding. Versus Noom, Hers is the more direct medication-first path but offers less behavioral coaching. If you want insurance billing or heavier coaching support, a different provider on our comparison table may fit better.
Who Hers is best for
Consider Hers if you want a fast, discreet, fully-online path to brand-name GLP-1s from a major, recognizable brand and you are comfortable paying cash. Look elsewhere if you need insurance to cover the cost, you want real-time video visits with a clinician, or you prefer a provider with a quieter regulatory track record.
The bottom line
Hers is a credible, mainstream option for online GLP-1 weight loss in 2026 — brand-name medications, a trusted public-company parent, and transparent (if not cheap) pricing. The two things to weigh are the all-in cost once the $149/month membership is added to the medication, and a regulatory history that, while now resolved, is more eventful than most competitors’. Read the cancellation terms before you subscribe.